Mesothelioma is an incurable cancer linked to asbestos, but a trial hopes to prolong patient lives.

Texas Center for Proton Therapy has been serving cancer patients in Dallas-Fort Worth and beyond for nearly a decade. The 63,000-square-foot facility located in Irving is one of approximately 45 ...

This page contains press release content distributed by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content. The placement of ...

LOS ANGELES (KABC) -- Proton therapy to treat prostate cancer has been available in Southern California for nearly 35 years. It's less invasive and offers fewer side effects compared to conventional ...

What: On today, February 23, 2026, the Maryland Proton Treatment Center (MPTC) will celebrate a momentous milestone – fighting cancer for +10 years with proton therapy. To commemorate this occasion, ...

Patients have an additional weapon to fight cancer as Radiation Medicine Associates’ eight physicians begin providing proton therapy this week at the new ProCure Proton Therapy Center, 5901 W.

Proton therapy is often a preferred form of radiation for cancers such as head and neck, brain, eye and lung. But other less common cancers may also benefit from this therapy. These can include ...

Proton Therapy reduces the risk of a second cancer diagnosis by 69% versus other forms of radiation treatment according to a paper recently released by a team from Stanford University. The study ...

While there are currently only 22 proton therapy centers in the United States, the growing interest in the advanced cancer therapy is causing more hospitals to weigh the benefits against the high cost ...

Annemarie Shepherd, MD, medical director of Fred Hutch Cancer Center – Proton Therapy, has a special interest in thymic cancers, a type of thoracic cancer. Thoracic cancers develops in the chest, or ...

Derek Tsang receives research grant funding from ACCESS (https://accessforkidscancer.ca), the Brain Tumour Foundation of Canada, and the US National Cancer Institute. Tsang also received travel ...

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical company, recently acquired Liora Technologies, ...